The Journal of Advanced Therapies Journal (ATJ) aims to foster the advancement and dissemination of scientific knowledge in the field of bioengineering and pharmacological sciences. It provides a platform for researchers, scientists, academicians, and professionals to publish their original research findings, reviews, and commentaries.
The scope of ATJ encompasses a wide range of topics within the biological and pharmacological sciences, including but not limited to:
- Stem Cell Research & Therapy
- Gene therapy
- Cytotherapy
- Regenerative Therapy
- Cell Transplantation
- Cellular and Molecular Bioengineering
- Cellular Reprogramming
- Biomaterials and Tissue Engineering
- Stem Cells Translational Medicine
- Drug Absorption and Distribution
- Drug Discovery & Design
- Drug Metabolism and Excretion
- Experimental Pharmacology
- Endocrine and Reproductive
- Novel digital health approaches
- Large digital medicine / digital therapeutics trials with clinical impact
- the development of novel techniques for gene therapy research and improvements on established tools
- gene-based vaccine development and applications
- cell-based therapies including all aspects of stem cells and genetically modified cellular approaches
- novel genetic biomarkers of disease susceptibility or disease progression with extensive scientific validation
- preclinical animal model systems and validation studies
- Clinical protocols
- Commercial development of gene and cell therapy products
- Inflammation and Immunopharmacology
- Molecular and Cellular pharmacology
- Neuropharmacology
- Pharmaceutical Chemistry
- Advances in Pharmaceutical Analytical Methods
- Cardiovascular Pharmacology
- Cancer Pharmacogenomics
- Cellular and Molecular Pharmacology
- Chemotherapy, Antibiotics and Gene Therapy
- Clinical Pharmacology and Therapeutics
- Pharmaceutical Drugs
- Pharmaceutical Technology
- Pharmaceutical Toxicology and Metabolic Inhibitors
- Pharmacoeconomic in Drug Development
- Pharmacogenetics
- Pharmacogenomics
- Pharmacogenomics Future Medicine
- Proteomics and Pharmacodynamics
- Systems Pharmacology
- Theoretical Pharmacology
- Translational Medicine
- Precision oncology
- Molecular profiling
- Biomarker diagnostics
- Optimal therapy
The Editors' Choice articles are handpicked by the editorial team of Advanced Therapeutics to show case the very best that the journal has to offer. The Editors' Choice collection will be updated regularly with outstanding new articles for you to read and share.
Advanced Therapies Journal was first published in 2018 as pharmacogenomics and Omics technologies Journal and in 2023 reviewed for optimization and reformed to advanced therapies journal. Now ATJ is a premium home for the publication of interdisciplinary research on the next-generation of therapeutics and advanced therapies. The articles selected for the Editors' Choice are representative of the key topics that the journal publishes, including targeted drug delivery; drug discovery; cellular, genetic, and immunotherapies; personalized and precision medicines; theranostics; omics technologies, tissue engineering, pharmacology; toxicology, and highlight work done by researchers from across the globe.
Keep an eye out for the monthly issues of Advanced Therapeutics, and bookmark this webpage to stay up-to-date with the latest top-level articles.
From the editorial office, we hope you will enjoy browsing through our Editors' Choice!